The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-1-(3-(pyridin-4-yl)propyl)-3-(1-(thiophen-2-yl)cycloheptanecarbonyloxy)-1-azoniabicyclo[2.2.2]octane ID: ALA3087230
PubChem CID: 72545528
Max Phase: Preclinical
Molecular Formula: C27H37N2O2S+
Molecular Weight: 453.67
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O[C@H]1C[N+]2(CCCc3ccncc3)CCC1CC2)C1(c2cccs2)CCCCCC1
Standard InChI: InChI=1S/C27H37N2O2S/c30-26(27(25-8-6-20-32-25)13-3-1-2-4-14-27)31-24-21-29(18-11-23(24)12-19-29)17-5-7-22-9-15-28-16-10-22/h6,8-10,15-16,20,23-24H,1-5,7,11-14,17-19,21H2/q+1/t23?,24-,29?/m0/s1
Standard InChI Key: HNKRLZPRTHVMQJ-IDPZRHLESA-N
Molfile:
RDKit 2D
32 36 0 0 0 0 0 0 0 0999 V2000
15.1542 -5.6034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4377 -6.0010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4288 -6.8187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1538 -7.2191 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.8524 -6.8400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8630 -6.0120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6275 -6.2296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3706 -6.5690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7311 -5.5835 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.3820 -5.1310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8376 -5.7530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9292 -5.7499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6243 -4.8096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3978 -4.0190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8750 -3.3482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6931 -3.3142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2396 -3.9295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1005 -4.7413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0199 -5.6830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6973 -6.4416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3193 -6.9857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0236 -6.5608 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
12.6722 -6.5298 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.0452 -8.0331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6965 -8.5363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5879 -9.3503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2392 -9.8493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1253 -10.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7758 -11.1655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5366 -10.8504 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.6431 -10.0318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9916 -9.5366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 7 1 0
4 8 1 0
7 8 1 0
2 9 1 6
11 10 1 0
10 12 1 0
13 14 1 0
14 15 1 0
15 16 1 0
13 10 1 0
16 17 1 0
10 18 1 0
17 18 1 0
11 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 11 1 0
12 23 2 0
12 9 1 0
4 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 27 1 0
M CHG 1 4 1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 453.67Molecular Weight (Monoisotopic): 453.2570AlogP: 5.52#Rotatable Bonds: 7Polar Surface Area: 39.19Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 5.65CX LogP: 1.54CX LogD: 1.53Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.31Np Likeness Score: -0.15
References 1. Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V.. (2013) The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD., 23 (23): [PMID:24144851 ] [10.1016/j.bmcl.2013.09.092 ]